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Previous research has suggested the prevalence of certain personality traits, some of 
which are related to a disorganized attachment, in substance abuse disorders. Further, 
frustration tolerance (FT) has been proposed as an important factor in addiction, both 
at the inception—following the “self-medication” hypothesis—and regarding treatment 
compliance. In turn, an inadequate response to frustrating events has been also 
associated with a disrupted attachment. Our goal is to explore the mediational role of FT 
in the relationship between personality traits and two different treatments for substance 
addiction: therapeutic community (TC) and ambulatory treatment (AT). Eighty-four subjects 
with substance abuse disorder were recruited in total (22 female), including 46 volunteers 
(13 female) in TC and 38 (9 female) in AT. They were assessed with Rosenzweig’s test 
for FT and the Millon Clinical Multiaxial Inventory-III (MCMI-III) test to evaluate personality 
factors. By comparing with a control sample (335 volunteers, 268 female), we found that 
FT was lower in patients. Between therapeutic groups, FT was significantly lower in TC. 
Depressive, antisocial, sadistic, negativistic, schizotypal, borderline, paranoid, anxiety, 
dysthymia, alcohol use, drug use, posttraumatic stress disorder (PTSD), thought disorder, 
and delusional disorder traits were suggestive of pathology in the clinical samples and 
were significantly different between control, AT, and TC groups. Further, anxiety and PTSD 
traits were higher in TC than in AT. A mediational analysis revealed that the effect of anxiety 
and PTSD scales on therapeutic group was partially mediated by FT. In conclusion, FT 
and its interplay with personality traits commonly related to disorganized attachment 
(anxiety and PTSD) might be important factors to consider within therapeutic programs 
for persons with substance addiction.
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INTRODUCTION
Drug addiction withdrawal implies a set of physiological and psychological challenges that should 
be faced by the patient and taken into account by the therapist (1–3). Physiological alterations 
appear a few hours after the cessation of drug administration, do not extend longer than 3 weeks 
(1), and can be alleviated by pharmacological treatment (4). However, psychological challenges are 
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more persistent (5), and pharmacological intervention is not 
always effective to treat them (6, 7). Frustration is one of the 
common negative emotions involved in withdrawal (8–18), and 
its experience during detoxification significantly contributes to 
relapse and treatment discontinuation (7). Moreover, following 
the self-medication hypothesis, it has been proposed that illicit-
drug consumption—and subsequent addiction—could be used as 
a means of alleviating negative emotions such as frustration (19).
Taking this into account, the ability of the patient to tolerate 
frustrating events might be an important factor in substance 
addiction, both in the development of the disorder and during 
treatment. Frustration is defined as a negative emotional response 
triggered after the omission and/or devaluation of an expected 
reward (20). Animal research has extensively demonstrated the 
influence of this negative emotion on substance abuse [see, for 
example, Ref. (21)]. Concerning humans, frustration tolerance 
(FT) is negatively associated with the number of relapses (22) and 
positively predicts recovery from alcoholism (23, 24). It is also an 
essential component of the complex construct of distress tolerance 
(25), which is, in turn, an important factor of withdrawal (26–28).
Previous studies have suggested the attachment hypothesis 
of addiction as an alternative to self-medication. Attachment is 
defined in developmental psychology as the emotional tie that 
connects the child with his or her main caregiver (29, 30). In 
her first works, Mary Ainsworth described three main types 
of attachment, namely, secure, anxious insecure, and avoidant 
insecure. Nowadays, the most common classification includes 
organized (secure, insecure–avoidant, or insecure–resistant) and 
insecure–disorganized attachment types (31). Within organized 
attachment, insecure children are hesitant to rely on their main 
caregiver in distress situations, due to a prior unreliable response 
from the adult. They are considered organized because children 
can develop strategies to handle stressful situations. In contrast, 
children with a disorganized attachment show a fearful, conflicted, 
or apprehensive behavior when reunited with their caregivers after 
distress (32). It is important to note that a disorganized attachment 
may co-exist with any of the organized subtypes, mostly insecure 
(33). In adults, insecure attachment is mostly manifested in 
enhanced avoidant and anxious behaviors. Like children, adults 
expect unresponsive peers in stressful situations, leading them to 
avoid close relationships or to desire proximity but lacking trust in 
their partners (32). Current research has proposed that an insecure 
(disorganized) attachment may be a risk factor for developing 
substance addiction (34–36). Moreover, a disorganized mother–
child attachment can be associated with poorer FT in children 
(37, 38), and adults with insecure attachment are prone to show 
problems coping with emotion regulation (39, 40). Therefore, since 
FT is a relevant factor for both the self-medication hypothesis of 
addiction and disorganized attachment (which in turn may be a 
risk factor for developing substance addiction), the assessment 
of FT in patients with substance use disorders may help bring 
together both fields of research.
Interestingly, other authors have highlighted the influence of 
personality traits on addiction and attachment. Magor-Blatch and 
collaborators (41) explored pathological symptoms and clinical 
syndromes, assessed by the Millon Clinical Multiaxial Inventory-
III (MCMI-III) (42), in a large sample of amphetamine-type 
substance users. They found scores in the pathological range in 
anxiety, bipolar, borderline, dependent, narcissistic, negativistic, 
and sadistic scales, although these values did not predict 
completion of the therapeutic program. Fernandez-Montalvo 
et al. (43) found that over 76% of patients in therapeutic 
community (TC) had a pathological personality, antisocial being 
the most prevalent trait (43%). Other studies report a significant 
presence of antisocial, anxiety, depressive, borderline, bipolar, 
and posttraumatic stress disorder (PTSD) traits in patients with 
substance dependency (44–47). Psychopathology is understood 
under the scope of attachment theory as an adaptive resource to 
compensate for an insecure attachment (48). Previous research 
has demonstrated a relationship between certain elements of 
a dysfunctional attachment (unresolved loss and unresolved 
trauma) and personality (49). Using the Adult Attachment 
Interview, these authors found that borderline and anxiety traits 
were higher in trauma inpatients with unresolved attachment. 
Furthermore, within the scope of the self-medication hypothesis 
of addiction, antisocial personality was described as a mediator 
of the relationship between alcohol consumption and parental 
bonds in male college students (50). Besides, other authors found 
a relationship between anxiety and insecure attachment styles 
in alcohol-addicted inpatients: anxiety traits were significantly 
higher in participants with insecure, compared with secure, 
attachment (51). Beyond the scope of addictive disorders, a 
disorganized attachment has been associated with higher values 
of paranoid, borderline, and histrionic traits in adults (52).
The present study intends to contribute to this field of research 
by evaluating personality traits and FT in subjects included in two 
different therapeutic approaches: TC and ambulatory treatment 
(AT). To the best of our knowledge, our research is the first to explore 
FT and personality traits in both types of treatment, since previous 
works have focused on TCs (11, 14, 22, 41, 53–55). Although we do 
not measure attachment directly, we aim to evaluate the association 
between the type of withdrawal program (TC and AT) (which is an 
indirect indicator of addiction severity and risk of social exclusion) 
(56), the presence of pathological personality traits that have been 
previously related to a disorganized attachment (i.e., antisocial, 
anxiety, PTSD, borderline) [see, for example, Ref. (57)], and the 
role of FT as a mediating factor between them.
Considering this, the objectives of our research are: 1) to evaluate 
FT in TC and AT groups; 2) to explore the personality traits of 
the whole clinical sample under study; 3) to compare personality 
traits between therapeutic groups, focusing on those previously 
related to disorganized attachment; and 4) to explore whether the 
influence of personality on treatment group is mediated by FT. A 
deeper knowledge of negative psychological emotions involved 
in withdrawal, such as frustration, and its mediation in the 
relationship between personality and treatment, may help improve 
these therapeutic programs and their probability of success.
METHODS
Participants
Participants under treatment for substance abuse were recruited 
through an advertisement made by the therapists of Asociación 
Frustration Tolerance, Personality, and Substance AddictionRamirez-Castillo et al.
3 June 2019 | Volume 10 | Article 421Frontiers in Psychiatry | www.frontiersin.org
Proyecto Hombre in the centers of Navarra and Granada. All 
volunteers signed an informed consent, and the protocol was 
approved by the Committee for Ethics in Research of the University 
of Navarra. Data were collected between 2015 and 2016. Proyecto 
Hombre verified, by means of urine tests, that participants were 
not consuming any drug—other than tobacco—during the 
2 weeks prior to their psychological assessment. The total number 
of participants was 84 patients (22 female) from both centers. Age 
ranged from 20 to 63 years (40.06 ± 1.10, mean ± standard error 
of the mean), and it was not significantly different between male 
(39.31 ± 1.17) and female (42.18 ± 2.58) participants: Student’s 
t(82) = −1.156, p = 0.251. Concerning the therapeutic program, 
46 participants (13 female) were in TC, whereas 38 received AT 
(9 female). The mean age of these groups was also similar: 
age(TC) = 38.70 ± 1.54, age(AT) = 41.71 ± 1.53; t(82) = −1.377, 
p = 0.172. A chi-square test of independence showed that gender 
composition was not different between therapeutic groups 
(χ2(1) = 0.225, p = 0.635). At the time of assessment, the duration 
of treatment was similar in both groups: TC, 4.12 ± 0.38 months; 
AT, 4.80 ± 0.34 months, t(82) = 1.317, p = 0.192. We did not 
collect information about psychopharmacological medication 
prescribed to volunteers (Table 1).
Inclusion criteria for the participants were: i) fulfilling the 
diagnostic criteria of the Diagnostic and Statistical Manual of 
Mental Disorders, 4th Edition, Text Revision (DSM-IV-TR) for 
substance dependence, substance abuse, and substance withdrawal; 
ii) participation in TC or AT for at least 2 weeks before data 
collection; and iii) presenting physical or psychological harm and/
or dependence due to substance consumption in the past.
In order to assess FT in substance abuse with respect to the 
general population, we recruited a control sample (N = 335, 
268 female), which included community controls (next of kin 
of the patients) and university students. Exclusion criteria were: 
1) alcohol or substance abuse or dependence, as assessed by the 
Alcohol Use Disorders Identification Test (AUDIT) and Alcohol, 
Smoking and Substance Involvement Screening Test (ASSIST) 
tests; 2) self-reported previous treatment for substance abuse 
dependence; and 3) self-reported history of neurological or 
mental disorders. All control participants signed the informed 
consent to take part in the study. This sample was not matched in 
terms of sex and age with the clinical group. Thus, in the Results 
section, we present three different strategies to compare FT 
between both samples. In addition, a subsample of 76 participants 
from the initial control sample was assessed with the MCMI-III 
questionnaire (see below and Table 1 for details).
Procedure and Therapeutic Strategies
Asociación Proyecto Hombre is a Spanish institution for treating 
and preventing addiction, involving 27 centers and 16,600 persons 
under treatment annually. They work in three fundamental 
areas: prevention, rehabilitation, and reintegration of former 
users (www.proyectohombre.es). The tests were conducted 
in the centers of Proyecto Hombre in the Spanish provinces of 
Granada and Navarra. Among others, they offer TC and AT 
therapeutic strategies. The former is inpatient, and the latter is 
outpatient, involving 1.5–2 h of treatment 5 days a week (Monday 
to Friday). Patients are assigned to either program depending on 
their preferences, as well as on the therapists’ recommendation 
based on their social situation. It is important to note that the 
assignment to TC points to a more compromised social and/
or pathological situation, since inclusion in TC is related to the 
fact that patients do not or cannot have employment, or they do 
not have enough social support to tackle withdrawal treatment 
by themselves (56). The most common profile of AT patients, 
however, is a jobholder supported by family and acquaintances. 
In spite of this, therapeutic strategy is the same in both programs: 
group therapy for psychological and emotional aspects such as 
problem solving, anxiety control, emotional regulation, or relapse 
prevention, for instance. The only difference, apart from the 
number of hours spent daily in the program, is the emphasis on 
achieving personal and social autonomy in TC. Although the total 
time spent in the program depends on each person, TC treatment 
usually lasts 6–10 months, and AT is maintained for at least 1 year. 
Participants were allowed to smoke tobacco before assessment, so 
nicotine withdrawal is not expected to influence the study.
All data were anonymized and coded for each participant. 
First, the MCMI-III test was administered for approximately 
45  min. Then, subjects were evaluated with the Rosenzweig 
test for about 25 min. After a short break in the same room, 
participants were screened for substance use, abuse, dependency, 
and damage. This procedure was also followed by the control 
sample, although the MCMI-III test was administered only to a 
subsample of 76 participants, including university students and 
community controls.
TABLE 1 | Characteristics of the clinical and control samples included in the study.
Clinical Control Matched
TC AT Whole Whole MCMI Clinical Control
N 46 38 84 335 76 29 26
Age 38.7 ± 1.54
(20–60)
41.7 ± 1.53
(24–63)
40.1 ± 1.1
(20–63)
21.1 ± 0.32
(18–58)
23.2 ± 1.21
(18–58)
35.6 ± 2.16
(20–56)
36.3 ± 2.37
(20–58)
Gender
Female 13 9 22 268 59 21 20
Male 33 29 62 67 17 8 6
Treatment duration (months) 4.1 ± 0.38 4.8 ± 0.34 4.4 ± 0.04
Descriptive statistics are means ± standard errors of the mean. In parentheses, age range. “Matched” refers to samples randomly matched by MedCalc software (see Methods for 
details).
AT, ambulatory treatment; MCMI, subsample of control participants evaluated with the MCMI-III (see Methods for details); TC, therapeutic community.
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Questionnaires
Millon Clinical Multiaxial Inventory-III (MCMI-III). This test 
(42) is used for testing clinical personality patterns (11 scales), 
severe personality pathology (3 scales), clinical syndromes 
(7 scales), and severe clinical syndromes (3 scales). It consists of 
175 true/false items, and it also contains 3 control scales. This 
inventory identifies personality features underlying symptoms, 
and it is commonly used to assist clinicians in diagnosis and 
for therapy selection. According to the standards (58), scores 
between 60 and 74 are suggestive of symptoms at a subclinical 
level, values of 75–85 indicate presence and prevalence of the 
pathology or syndrome, and scores over 85 point to prominence 
of the pathology or syndrome.
Rosenzweig Picture Frustration Test, PFT. This is a semi-
structured projective test to assess tolerance or intolerance to a 
frustrating situation (59). It consists of 24 vignettes where pairs 
of characters are interacting. The subject assumes the role of one 
of the characters and provides his or her expected behavior in 
that situation. The test provides an FT index that is calculated 
through a simple procedure: the response for each vignette is 
scored by two different raters (from 0 to 2) considering the degree 
of aggression, avoidance, blocking, or coping (2 = aggressive 
response, 0 = non-emotional response). In our study, inter-rater 
reliability of this assessment was very high (average intraclass 
correlation coefficient = 0.943). In spite of the high reliability, the 
final score of each vignette was agreed upon in case of a mismatch 
between the raters. Higher scores indicate lower FT (higher level 
of aggressive response).
Substance use, abuse, and dependence. All participants were 
screened with a 13-item test to identify the substances they used 
(in the case of patients, before joining the therapeutic program) 
(alcohol, ecstasy, heroin, speed, cocaine, caffeine, tobacco, 
cannabis, hallucinogens, tranquilizers, and marijuana). The 
two last items indicated substance dependency and physical or 
psychological harm due to substance consumption. This test 
is based on the ASSIST 3.0, published by the World Health 
Organization (WHO) (60).
Subjects were also screened with the AUDIT (WHO) in its 
Spanish version (61).
STATISTICAL ANALYSIS
All statistical analyses were performed in Stata 12.1. We present 
three different strategies to compare FT between both samples: 
1) unpaired t test including all subjects (clinical vs. control sample); 
2) multiple regression to predict FT (dependent variable) from 
group (case = 1, control = 0), controlling by age and sex (male = 1, 
female = 0); and 3) randomly choosing age- and sex-matched 
subsamples of both groups with MedCalc (Ostend, Belgium) and 
then comparing FT with an unpaired t test. In order to achieve 
matching, the software randomly selected the maximum number 
of cases within group that produced non-significant differences 
between groups for age and sex. Therefore, matches were not 
necessarily exact. A Shapiro–Wilk test was conducted to assess 
normality. For normally distributed samples, means and standard 
errors of the mean are reported; for non-normal distributions, we 
report medians and interquartile ranges (IQRs). Comparisons 
between therapeutic groups were carried out with parametric t 
tests, due to sample sizes larger than 30. A multivariate analysis 
of variance (MANOVA) was used to test the omnibus differences 
in personality traits between therapeutic groups. The effect of 
covariates (i.e., duration of treatment) was assessed with analysis 
of covariance (ANCOVA) and a MANOVA, respectively.
In order to assess the mediational role of FT on the influence 
between personality traits and therapeutic group, we performed 
mediational analyses as described by MacKinnon and Dwyer 
(62), and as explained by Kenny (63). We used the command 
binary_mediation available in Stata’s repositories. In our case, 
we wanted to test whether the relationship between certain 
personality traits (for example, anxiety) and the assignment to a 
particular therapeutic group (TC or AT) was influenced by FT. In 
short, the analysis explores first the total effect of the independent 
variable (i.e., anxiety personality trait) on the dependent variable 
(i.e., inclusion in either AT or TC), in this case with a logistic 
regression (AT = 0, TC = 1). Then, the total effect is divided into 
the direct effect (the influence of the independent variable, i.e., 
anxiety) on the dependent variable (AT or TC) controlling for 
the mediator (FT) and the indirect effect (the influence of the 
independent variable, i.e., anxiety) on the mediator (FT), and 
the effect of the mediator (FT) on the dependent variable (AT 
or TC); if the direct effect is negligible and the other tests are 
significant, the mediational role of the variable may be assumed. 
Practically, to fully assess the mediational role of a variable, four 
steps must be fulfilled: 1) the independent variable (i.e., anxiety) 
must have an effect on the dependent variable (treatment: TC = 
1 or AT = 0); 2) the independent variable must have a significant 
effect on the mediational variable (FT as assessed by the PFT); 
3) the mediational variable must have a significant effect on 
the dependent variable when controlling for the independent 
variable; and 4) the direct effect of the independent variable on 
the dependent variable, when controlling for the mediational 
variable, must be null (total mediation), or at least lower than 
when the mediational variable is considered (partial mediation).
Step 1 is assessed by a logistic regression and gives the total 
effect of the independent variable on the dependent variable 
(coefficient c). Step 2 is evaluated by a linear regression, taking FT 
as the dependent variable and the personality trait as predictor, 
and it provides coefficient a. Steps 3 and 4 are assessed with a 
logistic regression, including treatment as the dependent variable 
and the personality trait and FT as predictors. The influence of 
FT on treatment (controlling by personality trait) is coefficient b 
in the mediational model, and the effect of the personality trait 
on treatment (controlling for FT) is coefficient c’.
RESULTS
Frustration Tolerance
Overall, the whole clinical sample (AT and TC) showed a score 
of 16 ± 6.5 (median ± IQR; Shapiro–Wilk p = 0.0235) in the 
Rosenzweig test (Figure 1). This is considered a medium FT 
according to the standards, as defined by Rosenzweig and based 
on the Dollard et al. theory of frustration–aggression (64), 
Frustration Tolerance, Personality, and Substance AddictionRamirez-Castillo et al.
5 June 2019 | Volume 10 | Article 421Frontiers in Psychiatry | www.frontiersin.org
and points to an avoidant or blocking behavior when facing 
frustrating situations, masking a desire for aggression that the 
subject intentionally conceals (65). Note that higher scores on 
this test indicate a lower FT.
The control sample showed lower values on average (8 ± 8, 
Shapiro–Wilk p < 0.0001) (Figure 1), which reflect a strategic 
resolution of the frustrating vignettes based on social skills, 
empathy, and assertiveness. The comparison between these 
samples, unmatched for sex and age, yielded statistically significant 
results: t(417) = −9.99, p < 0.001, Cohen’s d = 1.22, pointing to 
a better FT in controls than in the clinical sample. In order to 
test whether this result was due to the difference in age (control, 
21.09 ± 0.32 yr; clinical sample, 40.06 ± 1.1 yr) or sex composition 
(control, 80% female; clinical sample, 26.2%), we performed a 
linear regression to predict FT values from group, sex, and age. 
A significant regression equation was found [F(3,415) = 33.178, 
p < 0.001, ηp² = 0.19], with a corrected R2 = 0.188. The only 
significant regressor was group (p(group) < 0.001, p(sex) = 0.695, 
p(age) = 0.964), controlling by sex and age. Participants’ predicted 
FT was 9.18 + 7.10(group), where group was coded as 0 = control, 
1 = clinical sample. These results were confirmed by randomly 
selecting subsamples for each group with MedCalc (Ncontrol = 26, 
20 female; Nclinical = 29, 21 female; age(control) = 36.31 ± 2.37; 
age(clinical) = 35.55 ± 2.16). In this case, we used non-parametric 
statistics since N < 30: Mann–Whitney U = 63.5, z = -5.295, p < 
0.001, Cohen’s d = 1.815. In these subsamples, PFT was 10 ± 5 for 
controls and 18 ± 6 for the clinical sample (Figure 1).
In conclusion, as hypothesized, FT was lower in the clinical 
group than in the control sample, as measured by Rosenzweig’s PFT.
With respect to therapeutic groups, PFT values were higher 
in TC (18.22 ± 0.95, mean ± SEM; Shapiro–Wilk p = 0.0912) 
than in AT (13.34 ± 0.98; Shapiro–Wilk p = 0.0645) (Figure 1). 
As explained in the Methods section, these samples were 
matched for sex and age. A parametric t test confirmed statistical 
differences: t(82) = −3.54, p = 0.001, Cohen’s d = 0.78. Therefore, 
in accordance with our hypothesis, FT was lower in TC than in 
AT. Even though treatment duration was similar between groups, 
we performed an ANCOVA to confirm the difference between 
TC and AT in FT controlling for treatment duration (in months). 
As expected, between-group differences held when controlling 
by treatment duration at the time of assessment [F(1,25) = 1.83, 
p = 0.0302, ηp² = 0.07].
Personality Factors and Treatment Groups
We explored personality traits in TC and AT. Scores from the 
MCMI-III were processed as described by Millon et al. (58). All 
patients were assessed with this tool, whereas it was restricted to 
a subsample of 76 controls. Considering all the scales, Cronbach’s 
α was 0.90, showing a high internal consistency. With respect to 
individual subscales, values ranged from 0.9509 (borderline) to 
0.9556 (narcissist).
In order to analyze the clinical relevance of each personality 
trait, we focused on those that were significantly different between 
groups (control, AT, and TC) and with a median equal to or above 
60 for at least one of the clinical groups. Thus, we performed an 
ANOVA for each scale, using Bonferroni correction for multiple 
comparisons (p = 0.05/24 = 0.0021). Depressive, antisocial, 
sadistic, negativistic, schizotypal, borderline, paranoid, anxiety, 
dysthymia, alcohol use, drug use, PTSD, thought disorder, and 
delusional disorder traits fulfilled these criteria (Table 2). Due to 
the possible clinical relevance of these 14 scales, we focused on 
them for subsequent analysis.
In order to assess whether these personality traits were different 
between therapeutic groups, we performed a MANOVA with the 
MCMI scales as dependent variables and treatment group as an 
independent variable. There was a statistically significant difference 
between treatment groups in MCMI scales, F(14, 69) = 2.06, p = 
0.025, Wilks’ lambda = 0.705. As post hoc analyses, we performed 
two-tailed independent t tests for each variable, assuming a critical 
p value of 0.0036 (i.e., 0.05/14). Anxiety [t(82) = −3.42, p = 0.001; 
Hedges g = 0.743) and PTSD (t(82) = −3.23, p = 0.0018; Hedges g = 
0.703) survived this threshold (Table 3).
Influence of Personality Traits and Frustration 
Tolerance on Treatment Group
We hypothesized that FT may act as a mediational variable in 
the relationship between pathological personality traits and 
treatment group, which is an indicator of addiction severity. 
In order to test mediation, we followed the recommendations 
FIGURE 1 | Box plots showing differences in frustration tolerance (FT) between clinical and control samples, as well as between therapeutic programs.  
(A) Rosenzweig Picture Frustration Test (PFT) scores in the unmatched clinical and control samples. (B), median scores for the MedCalc-matched samples.  
(C) Rosenzweig PFT scores in therapeutic community and ambulatory treatment. Note that high values indicate poor FT.
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by Kenny (63), which assume the fulfillment of the four steps 
described in the Methods section of the present manuscript. We 
independently evaluated the effect of each scale suggestive of 
pathology (the 14 traits mentioned in the previous section) on 
treatment (TC = 1, AT = 0). Hence, we followed an approach 
suitable for dichotomous outcomes (66). Since we performed 
several different analyses, the critical p value was Bonferroni-
corrected (p = 0.05/14 = 0.0036).
As expected from the results of the previous section, only 
anxiety and PTSD survived Bonferroni correction when 
evaluating the influence of the independent variables (personality 
traits) on the dependent variable (treatment group) (Step 1): 
anxiety, χ2(1) = 10.91, p = 0.001; PTSD, χ2(1) = 9.80, p = 0.0017. 
These traits also influenced FT (Step 2), as assessed by a linear 
regression: anxiety, F(1,82) = 9.689, p = 0.003, ηp² = 0.106; 
PTSD, F(1,82) = 11.84, p = 0.0009, ηp² = 0.126. Both fulfilled 
Step 3, that is, PFT values significantly influenced treatment 
group when controlling for the corresponding personality trait 
(see standardized coefficients in Table 4): anxiety, BPTF = 0.107 ± 
0.044, p = 0.015; PTSD, BPTF = 0.110 ± 0.044, p = 0.013. Finally, 
the influence of each personality trait on treatment group was 
reduced when controlling for FT, although they remained 
significant (Step 4; see Table 4 for details): Banxiety = 0.020 ± 0.009, 
TABLE 2 | MCMI-III personality traits in the control, therapeutic community, and ambulatory treatment samples.
Control (N = 76) TC (N = 46) AT (N = 38) ANOVA F(2,157) p
Clinical personality patterns
 Schizoid 26 ± 34 53.5 ± 16 51.5 ± 33 19.23 <0.0001*
 Avoidant 32 ± 41 60 ± 30 51 ± 45 6.10 0.0028
 Depressive 25 ± 27.5 61 ± 23 53 ± 41 21.84 <0.0001*
 Dependent 42 ± 36 59.5 ± 24 53 ± 35 2.84 0.0616
 Histrionic 68 ± 24.5 35 ± 36 47 ± 35 36.94 <0.0001*
 Narcissist 63 ± 7.5 59.5 ± 21 64.5 ± 9 4.40 0.0138
 Antisocial 60 ± 29 70 ± 13 69.5 ± 13 30.55 <0.0001*
 Sadistic 45 ± 34.5 61.5 ± 16 64.5 ± 18 19.37 <0.0001*
 Compulsive 63 ± 28.5 34 ± 32 44 ± 27 28.81 <0.0001*
 Negativistic 44 ± 33 59.5 ± 14 61.5 ± 18 10.49 0.0001*
 Masochistic 20 ± 32.5 54.5 ± 11 52.5 ± 30 24.77 <0.0001*
Severe personality pathology
 Schizotypal 24 ± 53 60 ± 8 48 ± 38 11.98 <0.0001*
 Borderline 40 ± 43.5 65 ± 7 60 ± 31 21.53 <0.0001*
 Paranoid 48 ± 47 63.5 ± 13 63.5 ± 19 11.63 <0.0001*
Clinical syndromes
 Anxiety 41.5 ± 58.5 82 ± 17 59 ± 49 13.42 <0.0001*
 Somatoform 10 ± 27.5 46 ± 44 27.5 ± 42 7.71 0.0006*
 Bipolar 60 ± 38.5 70.5 ± 19 63.5 ± 29 5.61 0.0044
 Dysthymia 8 ± 29 64 ± 20 50 ± 46 38.83 <0.0001*
 Alcohol use 60 ± 45.5 77.5 ± 16 74.5 ± 20 44.98 <0.0001*
 Drug use 60 ± 33 89.5 ± 22 81 ± 25 74.58 <0.0001*
 PTSD 30 ± 50 60 ± 10 38 ± 52 11.38 <0.0001*
Severe clinical syndromes
 Thought disorder 33 ± 43.5 69.5 ± 24 43 ± 44 24.15 <0.0001*
 Major depression 12 ± 27 53.5 ± 36 33 ± 47 17.35 <0.0001*
 Delusional dis. 60 ± 61 63.5 ± 10 64 ± 8 13.25 <0.0001*
Median ± interquartile range is reported for all variables, since most of the traits (82%) followed a non-normal distribution. In gray, personality traits with a median ≥60 for any of the 
clinical samples and significant differences between groups (control, AT, and TC). 
*Significant differences between all three groups. Bonferroni correction is applied to determine critical p (0.05/24 = 0.0021).
AT, ambulatory treatment; TC, therapeutic community.
TABLE 3 | Between-group (clinical samples) differences in the MCMI-III 
personality traits suggestive of symptoms at a subclinical or clinical level.
TC (N = 46) AT (N = 38) t p
Clinical personality patterns
 Depressive 61 ± 23 53 ± 41 1.85 0.068
 Antisocial 70 ± 13 69.5 ± 13 2.02 0.047
 Sadistic 61.5 ± 16 64.5 ± 18 1.30 0.196
 Negativistic 59.5 ± 14 61.5 ± 18 0.29 0.77
Severe personality pathology
 Schizotypal 60 ± 8 48 ± 38 2.33 0.022
 Borderline 65 ± 7 60 ± 31 2.57 0.012
 Paranoid 63.5 ± 13 63.5 ± 19 0.77 0.44
Clinical syndromes
 Anxiety 82 ± 17 59 ± 49 3.42 0.001*
 Dysthymia 64 ± 20 50 ± 46 1.78 0.078
 Alcohol use 77.5 ± 16 74.5 ± 20 2.31 0.023
 Drug use 89.5 ± 22 81 ± 25 2.58 0.011
 PTSD 60 ± 10 38 ± 52 3.23 0.0018*
Severe clinical syndromes
 Thought disorder 69.5 ± 24 43 ± 44 2.85 0.0055
 Delusional dis. 63.5 ± 10 64 ± 8 0.49 0.622
Median ± interquartile range is reported.
*Significant differences between groups. Bonferroni correction is applied to determine 
critical p (0.05/14=0.0036).
AT, ambulatory treatment; TC, therapeutic community.
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p = 0.024; BPTSD = 0.023 ± 0.011, p = 0.037. The significance 
of direct and indirect effects in each case was tested using 
bootstrapping procedures on standardized coefficients (5,000 
samples), and the bias-corrected 95% confidence intervals are 
reported in Table 3 (see also Figure 2).
In other words, an increase of one standard deviation in anxiety 
and PTSD personality traits increases the odds of receiving TC 
treatment to 1.49 and 1.47, respectively. Part of this effect (27.7% 
in the case of anxiety and 32.1% for PTSD) was mediated by FT, 
suggesting the presence of hidden mediators.
DISCUSSION
The present results show an association between personality 
traits, FT, and two different therapeutic strategies to overcome 
substance abuse: TC and AT. Concerning MCMI-III, there 
were scores suggestive of pathology and significant differences 
between the control and clinical samples in depressive, antisocial, 
sadistic, negativistic, schizotypal, borderline, paranoid, anxiety, 
dysthymia, alcohol use, drug use, PTSD, thought disorder, and 
delusional disorder scales. Regarding personality and addiction, 
a previous report (41) analyzed personality factors in TCs of 
substance users. They also found scores in the pathological 
range in drug and alcohol use, antisocial, sadistic, and anxiety 
traits, among others. Overall, MCMI-III scores were higher in 
their study, but the general organization of clinical personality 
and syndrome scales resembles our results. The globally lower 
scores of our participants may be due to the different nature of 
the samples included in both studies: whereas the present report 
included subjects addicted to alcohol, marijuana, cocaine, or 
benzodiazepines, that of Magor-Blatch et al. (41) was restricted 
TABLE 4 | Mediational analyses between personality traits, frustration tolerance, and treatment group.
Total effects (c) Direct effects (c’) Indirect 
effect (a)
Indirect 
effect (b)
Total indirect 
effects (a*b)
% Total effect 
mediated
Anxiety β 0.399 0.289 0.325 0.340 0.111 27.7%
BC CI 95% 0.155, 0.625 0.041, 0.542 0.033, 0.229
PTSD β 0.387 0.263 0.355 0.350 0.124 32.1%
BC CI 95% 0.148, 0.602 0.040, 0.505 0.034, 0.259
a (indirect effect), effect of the personality scale on frustration tolerance; b (indirect effect), effect of frustration tolerance on treatment group (1 = therapeutic community, 0 = 
ambulatory treatment), controlling for the corresponding personality trait; β, standardized coefficient; BC CI 95%, bias-corrected 95% confidence interval after bootstrapping 
standardized coefficients; c, total effect of personality scale on treatment group; c’, direct effect of personality trait on treatment type controlling for frustration tolerance.
FIGURE 2 | Mediation analyses between personality traits, FT, and treatment program (therapeutic community or ambulatory treatment). Personality traits are anxiety 
(A) and PTSD (B). Numbers are standardized regression coefficients. Paths from each personality trait to FT correspond to coefficient a; paths from FT to treatment 
correspond to coefficient b; and paths between personality traits and treatment are total effects (c) (in parentheses, direct effect (c’) when controlling for FT).
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to amphetamine-type prior users. Besides, we administered the 
MCMI-III test two weeks after the initiation of the program, 
whereas they assessed participants at the commencement of 
the therapy. Interestingly, the control sample assessed with the 
MCMI-III in our research showed relatively high values (≥60) 
in several subscales (histrionic, narcissist, antisocial, compulsive, 
bipolar, alcohol and drug use, and delusional disorder). Whereas 
antisocial, alcohol and drug use, and delusional disorder scores 
were significantly lower than in the clinical samples, the median 
value for histrionic and compulsive traits was significantly higher 
in control participants than in patients. The latter result is not 
surprising, since elevated scores in histrionic, narcissistic, and 
compulsive scales have been extensively reported for nonclinical 
groups, pointing to normal traits; moreover, they are associated 
with less severity of the disorder when present in clinical samples 
(67). With respect to the relatively high values in alcohol and 
substance use, the absence of dependence and harm indicators 
based on the AUDIT and ASSIST justifies the consideration of 
this sample as “control,” compared with the clinical samples.
One of the main goals of our research was to seek differences in 
personality factors between TC and AT groups. To our knowledge, 
our study is the first to compare personality patterns of substance 
users between both programs. Previous reports have focused 
on TCs (11, 14, 22, 41, 53–55, 68), while studies on outpatients 
addressed low-intensity drug abuse such as tobacco (69, 70), 
alcohol, or cannabis (17). In our study, focusing on those scales 
with a putative pathological meaning (with scores ≥60) that 
showed significant differences between the three groups, patients 
in TC showed higher scores than those in AT in all of the traits 
that were statistically different between both clinical samples (see 
Table 3). Patients in TC are more vulnerable due to the higher 
severity of their condition and/or a risk of social exclusion; in the 
case of Proyecto Hombre, the institution that hosted the volunteers 
included in our study, the main reason to be included in TC is 
insufficient family or social support. This, together with a severe 
substance addiction disorder, may pose difficulties for the patient 
to find or retain a job, stable housing, and consequently solid 
ground to recover from his or her condition. Due to this, patients 
in TC are at a higher risk for social exclusion. Our results confirm 
significant differences in a number of scales, pointing to an overall 
pathological condition that should be considered during treatment. 
The subscales that showed significant differences were anxiety and 
PTSD, with medium-large effect sizes (Hedges g values above 
0.80 are considered large effects) (71). Previous research suggests 
usual co-morbidity of cocaine addiction with psychiatric disorders 
such as major depression, bipolar disorder, schizophrenia, PTSD, 
attention-deficit hyperactivity disorder (ADHD), anxiety, or 
borderline disorder (72). In fact, the European Monitoring Center 
for Drugs and Drug Addiction in 2015 stated that dual pathology 
and co-morbidity between drug addiction and mental disorders 
had risen up to 60%. According to our results, although we have 
not assessed co-morbidity per se, the higher scores in TC than 
in AT for most of the personality traits point to an enhanced 
vulnerability of patients in the former to develop mental disorders. 
This highlights the potential importance of a thorough personality 
profile before assigning a patient to either therapeutic program, as 
other authors suggest (6, 7).
With respect to negative emotional symptoms, our results 
show a lower FT in the clinical sample than in controls, and in 
TC compared with AT. The effect sizes of these results are quite 
large, indicating that about 96% of the matched control sample 
have better FT (lower scores) than the clinical sample, and about 
79% of the TC sample have lower FT than the AT sample. Hence, 
this construct may be an important distinctive factor in substance 
abuse. Different stages of addiction, and relapse in particular, have 
been understood as a behavioral response to overcome the negative 
emotions (dysphoria, anxiety, irritability, etc.) that occur after the 
cessation of drug administration (73). Our result on the difference 
in FT between patients and controls may point to a crucial role in 
the development of addiction itself: in the presence of frustrating 
situations, when negative emotions are linked to a response of the 
pituitary–hypothalamus–adrenal axis (74), a poorer management 
of frustration may lead to its alleviation through the euphoric 
effects of recreational drugs. As has been recently suggested in 
children, negative emotions such as frustration may be regulated 
by the lateral prefrontal cortex (75). Moreover, a poor FT may 
trigger treatment discontinuation or relapse during withdrawal 
(22). We show here that patients in TC, where more frustrating 
situations are expected to occur due to the radical change in daily 
conditions, have a lower FT even when excluding the effect of 
treatment duration. Therefore, we suggest that a specific treatment 
for frustration intolerance may be useful in TCs. These results fit 
well with the “strength model” of self-regulation, which uses the 
metaphor of muscular exercise (and fatigue) to explain a decrease in 
self-control under stressful situations, leading to an “ego depletion” 
(extreme fatigue of self-control) (76, 77). In our study, FT would 
be a manifestation of self-control, which would be “depleted” in 
a greater extent in TC patients, due to the more severe conditions 
of the treatment and their lack of social support. As we propose 
below, future longitudinal studies could help clarify this potential 
inclusion of FT within the strength model of self-regulation.
Furthermore, we propose that clinical personality traits, 
mediated by a poor FT, may influence addiction severity, which 
is manifested in the type of treatment in which the patient is 
enrolled. Thus, a particular set of clinical personality features 
could be associated with a worse prognosis; however, this total 
effect might be better understood by the mediating role of FT. 
According to our results, this is the case for anxiety and PTSD 
personality traits. For example, a one-standard-deviation (23.8) 
increase in the MCMI-III anxiety scale would increase the odds 
to receive TC treatment by 49%. If the mediating role of FT were 
excluded, the association between both variables would decrease, 
and the odds would only increase 33.5%. In other words, a poor 
FT worsens the addiction prognosis of patients with higher levels 
of anxiety or PTSD personality traits. To our knowledge, this is 
the first time that the interaction between personality and FT 
has been explored in the context of addiction, and our results 
may suggest new strategies to improve withdrawal treatments. 
On the other hand, our conclusions are in line with classical 
psychotherapeutic approaches, such as rational emotive behavior 
therapy (78). According to this, even though a negative emotion 
is important to understand a behavioral outcome, implicit beliefs 
have a more important role in such emotion and its causes. The 
final goal of therapists, according to this account, is to help patients 
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minimize anxiety, guilt, and depression by accepting themselves 
(79); alleviate their aggression by accepting others (80); and 
reduce their low FT by accepting negative events (81). Hence, 
frustration is considered a healthy negative emotion, but a low FT 
is an “irrational belief ” (78). Similarly, our results suggest that an 
improvement in FT, as a mediational variable, may alleviate the 
influence of more stable personality traits on addiction severity.
Our study has a number of limitations. One aspect that 
should be considered is the gender composition of the samples. 
Females were underrepresented, and therefore, the conclusions 
of the study could be driven by male participants. This is a usual 
caveat in studies about addictions. We tackled this limitation 
by randomly selecting age- and sex-matched subsamples with 
MedCalc software. Furthermore, the size of the patient sample 
was relatively small. Access to a clinical sample cognitively intact 
and willing to participate in a research project was limited; besides 
that, it was challenging to complete evaluation in all cases because 
of treatment discontinuation. With respect to the control sample 
and its personality assessment, median scores are relatively high 
(=60) for alcohol and substance use subscales; however, in our 
opinion, it qualifies as a control sample for two main reasons: 
1) large differences in these traits with respect to the clinical 
samples and 2) absence of alcohol and substance dependence 
and/or harm after evaluation with the AUDIT and ASSIST tools, 
which are more specific to detecting alcohol and substance 
problematic use. It should be taken into account that some of the 
participants in the control sample were the next of kin of those in 
the clinical sample. Therefore, a certain degree of similarity in the 
psychological variables that we assessed, such as personality traits, 
might occur due to an akin genetic or educational background. 
Considering this, the differences that were found become even 
more relevant. Concerning the assessment of FT, we used a semi-
projective test where participants were asked to explain how 
they would react in a frustrating situation. It could be criticized 
that we did not use a task that actually induced frustration in 
participants. However, construct validity of Rosenzweig’s PFT 
has been adequately confirmed (82), it is considered a useful 
tool in clinical practice (83), and it has been shown to predict 
actual problem solving and stress coping in experimental settings 
(84, 85). In any case, future research should confirm our results 
with tasks eliciting actual frustration. Also, we did not collect 
information about the psychopharmacological medication that 
volunteers in the clinical samples were taking. Finally, it should 
be considered that the interplay between personality, FT, and 
treatment should be adequately assessed in longitudinal studies, 
including rates of relapse and dropouts. The conclusions of our 
study justify further research to elucidate this relationship.
Our study also suggests future directions to investigate the 
relationship between addiction, personality, and attachment. 
One crucial limitation is that we did not assess attachment 
styles in any of our samples, although our results can be 
interpreted to draw some preliminary conclusions and 
inspire future research. First of all, previous results show the 
relationship between a disorganized attachment and a higher 
probability of suffering anxiety (86), depression (87), addiction 
(88), or PTSD (89), and expressing personality disorders such 
as borderline, avoidant, or antisocial, among others (90). 
In turn, recent research has shown an association between 
insecure attachment, alcohol/substance addiction, and an 
increased amount of borderline personality organization (57). 
Even though the borderline trait did not survive Bonferroni 
correction in our study, it was suggestive of symptoms at a 
subclinical level in the clinical samples included in our study. 
Moreover, the relationship between attachment styles and 
substance addiction has been proven to have a biological 
correlate, in particular, white matter integrity: in a sample of 
poly-drug users, Unterrainer et al. (91) showed a decreased 
fractional anisotropy compared with recreational users or non-
users. Furthermore, impairment of the superior longitudinal 
fasciculus and corona radiata was associated with an insecure 
attachment and negative affectivity. Interestingly, this research 
group previously found a relationship between white matter 
integrity, attachment styles, and personality factors in the 
aforementioned tracts (92): in this case, structural connectivity 
impairment positively correlated with anxious attachment and 
personality dysfunctioning, whereas white matter integrity 
positively correlated with openness and agreeableness.
Early attachment relationships, which are based on the 
mental models that children build about themselves, their 
interrelationships with their caregivers, and their environment, 
are essential for them to acquire the abilities of emotional 
management, attentional control, mentalizing, and autonomy 
(93). In turn, attachment theory is becoming strongly influential 
in research and intervention on personality disorders (94–96). 
According to Adshead and Sarkar (96), these disorders include 
an intrapersonal component (related to a dysregulation of 
arousal, impulse, and affect systems in response to stress), an 
interpersonal component (dysfunctional attachment patterns), 
and a social component (dysfunction in social behaviors). To 
some extent, our research covers an interpersonal (FT) and 
social component (substance addiction inpatient or outpatient 
treatment), which can be related with the interpersonal 
component. According to our results, anxiety and PTSD are 
those personality traits more affected in the TC group, and 
under the influence of FT, they predict the inclusion in TC or 
AT treatment. The link between attachment styles and anxiety 
has been extensively demonstrated [see, for example, the review 
by Ref. (97)]. According to these authors, anxiety is more 
frequent in adolescents who experienced resistant attachment 
during childhood compared to those with secure or avoidant 
styles. This association remained when considering attachment-
related negative experiences during childhood (such as parental 
divorce or loss) or attachment states of mind (i.e., preoccupied), 
instead of self-reported assessment of attachment. Similarly, 
PTSD has been related to disorganized attachment. For instance, 
unresolved attachment-related state of mind is associated with 
a higher risk (7.5) of expressing PTSD (98). Furthermore, 
posttraumatic symptoms through midlife and old age are 
associated with adult attachment insecurity (99). In conclusion, 
our results point to a plausible interplay between disorganized 
attachment, FT, and certain personality traits (mainly anxiety 
and PTSD) in substance abuse disorders. Future research 
on these topics from a unitary perspective may increase our 
understanding of substance addiction, improving prevention 
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policies, and hopefully designing improved individualized 
treatments for patients suffering this devastating disorder.
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